EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,658 | -82.3% | 41,500 | -59.1% | 0.00% | -100.0% |
| Q2 2023 | $71,456 | -61.0% | 101,500 | -50.3% | 0.00% | -50.0% |
| Q1 2023 | $183,282 | +33.6% | 204,350 | +75.7% | 0.01% | +20.0% |
| Q4 2022 | $137,234 | -71.5% | 116,300 | +81.9% | 0.01% | -72.2% |
| Q3 2022 | $482,000 | +20.2% | 63,950 | +0.4% | 0.02% | +28.6% |
| Q2 2022 | $401,000 | -22.4% | 63,700 | +2.2% | 0.01% | -6.7% |
| Q1 2022 | $517,000 | +59.1% | 62,300 | -0.5% | 0.02% | +66.7% |
| Q4 2021 | $325,000 | -20.3% | 62,600 | +2.4% | 0.01% | -25.0% |
| Q3 2021 | $408,000 | +200.0% | 61,150 | +283.4% | 0.01% | +200.0% |
| Q2 2021 | $136,000 | +0.7% | 15,950 | +4.9% | 0.00% | 0.0% |
| Q1 2021 | $135,000 | -27.8% | 15,200 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $187,000 | – | 15,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |